Building on its legacy of fostering impactful healthtech innovations, the CO-AX accelerator at Sahlgrenska Science Park opens its doors for the spring 2024 batch of entrepreneurial talent. This call is directed towards innovators and startups who are leveraging technology to address global health challenges.
CO-AX, the healthtech accelerator at Sahlgrenska Science Park, proudly acknowledges the recent achievements of VERIGRAFT, a prominent member of its life science community. VERIGRAFT has reached a major regulatory safety milestone in the TECVI-1 trial, further supported by extended funding from Vinnova CAMP for their arterial graft development project.
TECVI-1 trial: a major step forward
The
Sahlgrenska Science Park, a catalyzer for innovation and collaboration in the life science sector in Sweden, proudly announces CO-AX, an exciting rebranding of its non-profit accelerator for startup and scaleup companies.
Medicinaregatan 8A
413 46 Göteborg
